[Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)].
D001623:Betamethasone / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology* / Q000627:therapeutic use; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D008775:Methylprednisolone / Q000494:pharmacology; D011565:Psoriasis / Q000188:drug therapy*; D012867:Skin / Q000201:enzymology; D014222:Triamcinolone Acetonide / Q000494:pharmacology
D005938:Glucocorticoids; D005446:Fluocinolone Acetonide; D001623:Betamethasone; D005954:Glucosephosphate Dehydrogenase; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone; D008775:Methylprednisolone
der Glucose-6-phosphat-Dehydrogenase-Aktivität durch Glucocorticoide. Ein Beitrag zum Screening "antipsoriatischer" Wirkungen